Studies

Photo

News • Women and Men

Heart Disease: same symptoms, different care

Despite messages to the contrary, most women being seen by a doctor for the first time with suspected heart disease actually experience the same classic symptoms as men, notably chest pain and shortness of breath, according to a study led by the Duke Clinical Research Institute.

Photo

News • Successful dying

Researchers define the elements of a “Good Death”

For most people, the culmination of a good life is a “good death,” though what that means exactly is a matter of considerable consternation. Researchers at the University of California, San Diego School of Medicine surveyed published, English-language, peer-reviewed reports of qualitative and quantitative studies defining a “good death,” ultimately identifying 11 core themes associated…

Photo

News • Clinical trial results

Reporting by top academic centers remains poor

Dissemination of clinical trial results by leading academic medical centres in the United States remains poor, despite ethical obligations - and sometimes statutory requirements - to publish findings and report results in a timely manner, concludes a study in The BMJ.

Photo

News • Antibodies

A ‘silver bullet’ for Ebola viruses?

There may be a “silver bullet” for Ebola. Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) reported that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.

Photo

News • Body dysmorphic disorder

Online therapy can help

Internet based cognitive behavioural therapy (CBT) can help people affected by body dysmorphic disorder, finds a study published by The BMJ today. This is the largest clinical trial of body dysmorphic disorder ever conducted, and the first to evaluate the effect of an internet based programme for the condition.

Photo

News • σ=p*r/2h

Physics Law Applied to Improve Left-Sided Heart Failure

Cardiologists from 15 centers in 6 countries have evaluated a new approach for the treatment of Left-Sided Heart Failure under the leadership of Stefan D. Anker, MD, Ph.D., Professor of Innovative Clinical Trials at the Cardiology and Pulmonology Clinic in the Heart Center of the Medical University Göttingen (UMG). The investigators in the clinical evaluation entitled AUGMENT-HF demonstrated…

Photo

News • Study

A biomarker for multiple sclerosis

Patients with multiple sclerosis often receive a "hit and miss" treatment when the disease breaks out. A blood analysis is now for the first time able to reveal which of the two most important first-line drugs is better suited for which patients.

Photo

Article • Mortality

Death risk rises over weekends

New studies reveal the heightened risk of death that patients face if admitted to hospital over a weekend. Researchers have studied what effect the day of hospital admission has on death rates across England in 2013-2014, as well as on hospitals in other countries, such as Australia, the USA and The Netherlands. Report: Mark Nicholls

Photo

Article • Infection

Trial pitches MGB-BP-3 against clostridium difficile

Scientists at the University of Strathclyde in Glasgow have been working to identify compounds with important anti-infective activity and suitable for treating serious infectious diseases caused by bacteria and parasites, such as Clostridium difficile. Their work has led to the creation of the new drug known as MGB-BP-3 (MGB = minor groove binder). Report: Mark Nicholls

Digital and Computed Radiography: cost-efficiency is the key

Large patient volumes and a shrinking pool of skilled resources in the European healthcare industry are creating the need for efficient workflow solutions. Hence, hospitals will increasingly invest in digital radiography (DR) as the revival of the regional economy picks up pace. While the saturated computed radiography (CR) segment is declining in terms of both unit shipment and revenue, the…

Photo

News • Hematology

Flowing toward red blood cell breakthroughs

A team of researchers from Brown University, ETH Zurich, the Universita da Svizzera Italiana (USI) and Consiglio Nazionale delle Ricerche (CNR) is using America’s most powerful supercomputer to help understand and fight diseases affecting some of the body’s smallest building blocks.

Photo

News • Lung cancer

Immunotherapy superior to chemotherapy?

Researchers compared an immunotherapy and a chemotherapy drug in patients with non-squamous non-small cell lung cancer (NSCLC) whose disease continued to progress after first-line chemotherapy. They found that nivolumab improved overall survival and was generally well tolerated. The results are significant because options for patients whose lung cancer progresses after initial treatment are…

86 show more articles
Subscribe to Newsletter